Spreng Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$423K Hold
353
0.15% 54
2026
Q1
$325K Hold
353
0.15% 58
2025
Q4
$379K Hold
353
0.15% 59
2025
Q3
$269K Buy
353
+6
+2% +$4.46K 0.11% 70
2025
Q2
$270K Hold
347
0.11% 68
2025
Q1
$287K Hold
347
0.13% 67
2024
Q4
$268K Sell
347
-202
-37% -$167K 0.12% 70
2024
Q3
$486K Sell
549
-130
-19% -$117K 0.23% 56
2024
Q2
$615K Buy
679
+28
+4% +$22.4K 0.32% 51
2024
Q1
$506K Buy
651
+111
+21% +$79K 0.27% 56
2023
Q4
$315K Hold
540
0.2% 66
2023
Q3
$290K Buy
540
+65
+14% +$33.5K 0.21% 68
2023
Q2
$223K Buy
+475
New +$199K 0.18% 80

Other funds holding LLY

Spreng Capital Management's LLY Position: Q2 2026 in Review

Spreng Capital Management held its Eli Lilly (LLY) position steady in Q2 2026 at 353 shares worth $423K. The position accounts for 0.15% of the portfolio, ranked #54.

Spreng Capital Management first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. The position peaked at $615K in Q2 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Spreng Capital Management held 353 shares of Eli Lilly worth $423K as of Q2 2026.
  • Spreng Capital Management left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.15% of Spreng Capital Management's portfolio in Q2 2026, its #54 holding.
  • Spreng Capital Management first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • Spreng Capital Management's Eli Lilly position peaked at $615K in Q2 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Spreng Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.